Pharmaceutical Technology-10-02-2011
Pharmaceutical Technology
Pfizer Outlines Its Supply Strategy
October 02, 2011
Online Exclusives
35
10
John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.
Biopharmaceuticals from Plan to Production
October 02, 2011
Online Exclusives
35
10
Management of the product plan and details for biopharmaceutical production are included in an integrated review of biotechnology operations.
Inside EDQM: Mass Serialization to Combat Counterfeit Drugs
October 02, 2011
Inside EDQM
35
10
Europe establishes new collaborative system to track products.
Applying Dry Powder Coatings
October 02, 2011
Peer-Reviewed Research
35
10
The authors experiment with a resonant acoustic mixer as a method for dry powder coating.
Biotech Venture Funding Slips Below 2010 Levels
October 02, 2011
BioForum
35
10
Average deal size and amounts invested increased in the second quarter, but totals trail funding of last year.
Global Healthcare on the Ground: AAPS on Why Global HealthCare is Important Now
October 02, 2011
In the Field
35
10
AAPS Global Health Focus Group's Kishor M. Wasan discusses new initiatives.
Single-use Technologies in Fill–Finish Operations
October 02, 2011
Special Reports
35
10
Single-use components in the fill–finish line provides increased flexibility to multiproduct manufacturers.
Sustainability Outside the Box
October 02, 2011
Packaging Forum
35
10
Drugmakers and packagers are pursuing various initiatives to reduce their carbon footprints. This article contains bonus material.
Managing Business Risks During a Merger or Acquisition
October 02, 2011
Viewpoint
35
10
Getting the most value out of M&As requires proper upfront legwork.
Is Noncompliance Just Human Nature?
October 02, 2011
PharmTech Talk
35
10
Corporate management must be held accountable for quality at all levels.
Inside PIC/S: The Importance of PIC/S in a Globalized World
October 02, 2011
Inside PIC/S
35
10
Expanding the organization's mandate will strengthen inspections.
Quality Issues for Multiregional Clinical-Trial Materials
October 02, 2011
Special Features
35
10
The authors examine risk management relating to the quality issues of clinical-trial materials and discuss areas that would benefit from additional consideration and harmonization.
Reformulating Injectables for Oral Delivery
October 02, 2011
Special Reports
35
10
Could oral absorption-enhancing technologies change the shape of protein delivery?
Assessment of Large-Sample Unit-Dose Uniformity Tests
October 02, 2011
Peer-Reviewed Research
35
10
The authors describe the concept of the limiting discriminatory the limiting discriminatory threshold (LDT) as an objective means of evaluating the inherent quality requirement of a large-sample content-uniformity test.
Preparing for the Last War
October 02, 2011
Outsourcing Outlook
35
10
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
FDA/Industry Perspectives: Detection, Measurement, and Control in Manufacturing
October 02, 2011
Special Features
35
10
The authors summarize a recent FDA–PQRI workshop on process drift.
Q&A with Rao Tatapudy, Catalent
October 02, 2011
Industry Leaders
35
10
A Q&A with Rao Tatapudy, vice-president of scientific affairs at Catalent, on recent industry trends.
Time is of the Essence
October 02, 2011
Agent-In-Place
35
10
Letting contamination build up can cause multiple headaches.
OOS, OOT, OOC, and OOSC
October 02, 2011
Statistical Solutions
35
10
Current GMPs demand full understandng of out-of-control concepts. This article contains bonus material.
Report from India
October 02, 2011
In the Field
35
10
In an effort to balance bilateral trade, India is urging China to increase Indian pharmaceutical imports.
In the Spotlight October 2011
October 02, 2011
In the Spotlight
35
10
New product reviews for October 2011 focusing on analytical instrumentation.
The Matrixx Zicam Verdict
October 02, 2011
Special Features
35
10
The authors summarize the Matrixx Initiatives, Inc. v. Siracusano case's implications for industry.
Global Health Challenges Spur Vaccine Development
October 02, 2011
Washington Report
35
10
Manufacturers fund research and reduce prices to tackle diseases.
Sizing Up the Global Market for Excipients
October 02, 2011
Pharma Ingredients
35
10
The global excipients market shows moderate growth, increased consolidation, and expansion activity in emerging markets and select product areas.
Advancing with the Times
October 02, 2011
Guest Editorial
35
10
Despite new hurdles, industry must move forward and fulfill its mission.
PQRI Case Study (4): Process Deviation and Empty Product Capsules
October 02, 2011
Special Features
35
10
This risk-management case study focuses on assessing empty capsules.
Pharmaceutical Technology, October 2011 Issue (PDF)
October 02, 2011
Issue PDF
35
10
Click the title above to open the Pharmaceutical Technology October 2011 issue in an interactive PDF format.